Pushing Psychedelics as A solution to Addiction

Let’s cut through the hype: pushing psychedelics as a “solution” to addiction is dangerously simplistic—and coming from someone like Joe Rogan, it’s exactly the kind of oversold narrative that gets people hurt.

We’re already living through the consequences of this mindset. Doctors once confidently prescribed opioids and other medications, assuring people they were safe. That didn’t just fail—it helped fuel one of the worst addiction crises in modern history. Now the pitch is basically, “trust us, this different class of drugs will fix it.” That’s not innovation—that’s amnesia.

Addiction—Substance Use Disorder—isn’t a chemical glitch you reset with another substance. It’s a behavioral, psychological, and social disorder. Telling people the answer lies in taking a psychedelic risks reinforcing the exact thinking that keeps people stuck: that relief comes from a substance instead of real, sustained change.

And the research people love to cite It’s happening in tightly controlled clinical trials with screening, therapists, and structured follow-up. That’s a world away from real life. Strip away that framework, and you’re not left with a miracle—you’re left with another powerful drug, unpredictable effects, and a population already vulnerable to misuse.

There’s also a glaring contradiction here. On one hand, there’s criticism of doctors and pharmaceutical companies for overprescribing addictive drugs. On the other hand, there’s enthusiasm for introducing psychedelics into the same ecosystem. If the system got it wrong before, why should anyone trust it to get this right—especially without long-term data.

And here’s the uncomfortable truth: not everyone benefits from psychedelics. Some people experience severe anxiety, dissociation, or even psychotic episodes. For individuals struggling with addiction or mental health instability, that’s not “therapy”—that’s risk.

Real recovery isn’t flashy. It’s therapy, accountability, community, and in some cases carefully monitored medications with decades of data behind them. It’s slow, difficult, and unglamorous—which is probably why it doesn’t make for great podcast content.

So no, psychedelics aren’t some revolutionary fix waiting to save people from addiction. At best, they’re an experimental tool that might have a narrow, controlled use someday. At worst, they’re the next chapter in a long history of overpromising drugs as answers to deeply human problems—and we’ve already seen how that story ends.